Tags

Type your tag names separated by a space and hit enter

Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19.
Clin Microbiol Infect. 2020 09; 26(9):1276-1277.CM

Authors+Show Affiliations

Dutch Medicines Evaluation Board, Utrecht, the Netherlands. Electronic address: s.gevers@cbg-meb.nl.Dutch Medicines Evaluation Board, Utrecht, the Netherlands.Dutch Medicines Evaluation Board, Utrecht, the Netherlands.Dutch Medicines Evaluation Board, Utrecht, the Netherlands; Haga Teaching Hospital, Department of Internal Medicine, The Hague, the Netherlands.

Pub Type(s)

Letter

Language

eng

PubMed ID

32422406

Citation

Gevers, S, et al. "Safety Considerations for Chloroquine and Hydroxychloroquine in the Treatment of COVID-19." Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases, vol. 26, no. 9, 2020, pp. 1276-1277.
Gevers S, Kwa MSG, Wijnans E, et al. Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19. Clin Microbiol Infect. 2020;26(9):1276-1277.
Gevers, S., Kwa, M. S. G., Wijnans, E., & van Nieuwkoop, C. (2020). Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19. Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases, 26(9), 1276-1277. https://doi.org/10.1016/j.cmi.2020.05.006
Gevers S, et al. Safety Considerations for Chloroquine and Hydroxychloroquine in the Treatment of COVID-19. Clin Microbiol Infect. 2020;26(9):1276-1277. PubMed PMID: 32422406.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19. AU - Gevers,S, AU - Kwa,M S G, AU - Wijnans,E, AU - van Nieuwkoop,C, Y1 - 2020/05/16/ PY - 2020/04/27/received PY - 2020/05/07/revised PY - 2020/05/07/accepted PY - 2020/5/19/pubmed PY - 2020/9/4/medline PY - 2020/5/19/entrez SP - 1276 EP - 1277 JF - Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases JO - Clin Microbiol Infect VL - 26 IS - 9 SN - 1469-0691 UR - https://www.unboundmedicine.com/medline/citation/32422406/Safety_considerations_for_chloroquine_and_hydroxychloroquine_in_the_treatment_of_COVID_19_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S1198-743X(20)30283-4 DB - PRIME DP - Unbound Medicine ER -